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Abstract
HLA-B*27:05 is associated with the development of autoimmune spondyloarthropathies,
but the precise causal relationship between the MHC haplotype and disease pathogenesis
is yet to be elucidated. Studies focusing on the structure and cellular trafficking of HLA-
B*27:05 implicate several links between the onset of inflammation and the unusual confor-
mations of the molecule inside and at the surface of antigen presenting cells. Several lines
of evidence emphasize the emergence of those unnatural protein conformations under con-
ditions where peptide loading onto B*27:05 is impaired. To understand how cellular factors
distinguish between poorly loaded molecules from the optimally loaded ones, we have
investigated the intracellular transport, folding, and cell surface expression of this particular
B27 subtype. Our findings show that B*27:05 is structurally unstable in the absence of pep-
tide, and that an artificially introduced disulfide bond between residues 84 and 139 conferred
enhanced conformational stability to the suboptimally loaded molecules. Empty or subopti-
mally loaded B*27:05 can escape intracellular retention and arrive at the cell surface leading
to the appearance of increased number of β2m-free heavy chains. Our study reveals a gen-
eral mechanism found in the early secretory pathways of murine and human cells that apply
to the quality control of MHC class I molecules, and it highlights the allotype-specific struc-
tural features of HLA-B*27:05 that can be associated with aberrant antigen presentation
and that might contribute to the etiology of disease.
Introduction
Major histocompatibility complex (MHC) class I molecules are transmembrane glycoproteins
playing a key role in the anti-viral and anti-tumor immune response, by presenting antigenic
peptides to cytotoxic T lymphocytes, which then kill aberrant cells. The assembly of the class I
heavy and light chains (beta-2 microglobulin, β2m) as well as the antigenic peptide ligand
takes place in the endoplasmic reticulum (ER). The binding of the peptide involves the con-
certed action of various proteins forming the peptide loading complex (PLC): the lectin chap-
erone calreticulin, binding to the N-linked glycans of the heavy chain; the disulfide isomerase
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ERp57, triggering disulfide bonding; the transporter associated with antigen processing
(TAP), channeling the peptides generated in the cytosol into the ER lumen; and the class I-spe-
cific chaperones tapasin and TAPBPR, which are involved in peptide editing [1–3]. Binding of
a high-affinity peptide to the class I-β2m heterodimer is decisive for the further fate of the com-
plex inside the cell, since suboptimally loaded class I molecules (bound to low-affinity peptides
or possibly even devoid of any peptide) do not reach the cell surface under normal conditions
but are retained in a cycle between the compartments of the early secretory pathway (ER,
ER-Golgi intermediate compartment (ERGIC), and the cis-Golgi) instead [4–6]. Another qual-
ity control takes place at the plasma membrane, where class I molecules eventually lose their
peptide and β2m, causing endocytic destruction of the heavy chain via its transport to degrada-
tive compartments [7,8].
Comparative molecular dynamics (MD) simulations on empty and peptide-bound class I
molecules have shown an increased flexibility of the empty peptide binding domain, especially
around the F pocket where the peptide C terminus binds [9,10]. Fluctuations in this region
might be recognized by cellular quality control mechanisms. Indeed, the murine class I mole-
cule H-2Db was stabilized with only a partial ligand corresponding to the C-terminal portion
of an optimal peptide [11]. Further molecular dynamics and experimental studies have con-
firmed the influence of the peptide C terminus on stabilizing the F pocket region, which domi-
nates the conformational and thermodynamic properties of the protein and is surveyed by the
cellular quality control [12]. In agreement with these findings, folded conformation of the F
pocket of the murine class I molecule H-2Kb can be preserved in a peptide-independent man-
ner by introducing an artificial disulfide bond resulting in restricted mobility of this region
[13]. As a result, the disulfide mutant can reach the cell surface in its suboptimally loaded state
and shows an increased half-life there, thus circumventing the quality control mechanisms
mentioned above.
The human leukocyte antigen HLA-B27 is one of the most prominent and thoroughly stud-
ied MHC class I molecules due to the genetic association of some of its subtypes, such as
B27:05 and B27:04 with ankylosing spondylitis (AS) and acute anterior uveitis [14–16].
While the molecular mechanisms underlying AS pathogenesis remain unclear, studies empha-
size various lines of possibilities. Interestingly, while a major line of evidence point to altered
peptide presentation via AS-related B27 subtypes [17], induction of inflammation by non-con-
ventional B27 structures (i.e. disulfide-linked B27 heavy chains) in case of poor peptide loading
has also been suggested [18].
We have previously attempted to understand the molecular features of B27 subtypes that
confer susceptibility to AS by comparing disease-related subtype B27:05 with the disease-
unrelated B27:09. MD simulations and in vitro analyses revealed increased molecular disorder
in the alpha helices involved in the F pocket region in the 05 subtype compared to the 09, lead-
ing to a general instability of the heavy chains of B27:05 [12]. In order to test whether B27:05
can be conformationally stabilized by limiting the mobility of this region, we constructed an F
pocket disulfide mutant of B27:05 by linking residues 84 and 139 with a disulfide bond, and
we investigated its cellular maturation and behavior at the cell surface. Our analyses reveal that
the A139C/Y84C mutant (hereafter referred to as B27:05-Y84C) has increased thermal stabil-
ity and β2m affinity, and that it can reach the cell surface in the absence of optimal peptides.
This confirms the importance of the F pocket for MHC class I quality control in cells and dem-
onstrate that this region can artificially be stabilized not only in murine but also in human
class I allotypes.
Stabilized HLA-B27 reaches the cell surface without peptide
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Materials and methods
Cell lines, antibodies and peptides
Human TAP2-deficient STF1 cells [19,20] were maintained using standard protocols. The
TAP2-reconstituted cell line STF1-TAP2 was generated by introducing the human TAP2 gene
into the STF1 cells by viral transduction as described previously [13]. We used the monoclonal
antibodies W6/32, a conformation-specific anti-HLA antibody [21], BBM.1, human β2m-spe-
cific antibody [22], and anti-HA (influenza virus hemagglutinin) antibody (clone 12CA5). For
the detection of TAP2, a monoclonal antibody (429.3) was used (kind gift from Peter van
Endert, INSERM, Paris, France). Calnexin was detected using the polyclonal rabbit antiserum
produced and kindly provided by David B. Williams (University of Toronto, Toronto, Can-
ada). AlexaFluor 488 (AF488)-conjugated goat anti-mouse immunoglobulin G was purchased
from Dianova (Hamburg, Germany). Immunofluorescence microscopy was performed as
described previously [12]. Sequences of all peptides are given in the standard single-letter
amino acid code. The high-affinity peptide (origin: human Cathepsin A) IRAAPPPLF and
IRAAPPPK(Biotin)F were synthesized by Genecust (Ellange, Luxembourg), purified by HPLC
to>90% (W/W).
Plasmids and retroviral expression
The A139C and Y84C mutations and the HA epitope tag (YPYDVPDYA) were sequentially
introduced into the wild-type HLA-B27:05 sequences by QuikChange site-directed mutagen-
esis (Agilent). Constructs were subcloned into pEGFP-N1 via XhoI and BamHI and used in
fluorescence microscopy experiments. The N-terminally HA-tagged HLA-B27:05 expression
construct (wild type and Y84C) were also cloned into puc2CL6IPwo via the XhoI and BamHI
sites. Lentiviruses were produced and used for gene delivery as described previously [23]. In all
experiments (except for microscopy, where N-terminal HA and C-terminal GFP double
tagged versions were used), B27 constructs that were only tagged with HA at their N termini
were used.
Flow cytometry
Cells were harvested via trypsinization, fixed in sodium azide (0.02% in PBS), and stained with
12CA5 against the HA epitope tag or with W6/32 against HLA and were kept on ice. After
washing, antibody-antigen complexes were labeled with secondary antibody conjugated with
AlexaFluor488. Surface staining was recorded by a CyFlow1Space flow cytometer (Sysmex-
Partec, Norderstedt, Germany) and analyzed by Flowjo, LLC software. Presented histograms
depict fluorescence measurements from intact cells that were gated according to their forward
and side light scattering properties.
Metabolic labeling and pulse-chase analysis
In pulse-chase and thermostability analyses, newly synthesized HLA-B27:05 molecules were
labeled with 35S-labeled methionine and -cysteine (EasyTag EXPRESS-35S protein labeling
mix, PerkinElmer) as described previously [24]. Briefly, cells were pulse labeled for 7 min and
chased in complete growth medium containing excess amounts of unlabeled methionine and
cysteine for 30, 60, 120, and 240 min, respectively. At the end of the chase period, cells were
lysed in native lysis buffer (50 mM TrisCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% (v/v) Tri-
ton X-100) for one hour and folded HLA molecules were immunoprecipitated with W6/32
coupled to Protein A-agarose beads (Calbiochem, Merck Millipore). Beads were washed twice
with wash buffer (50 mM TrisCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 0.1% (v/v) Triton X-
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100) and boiled at 95˚C for 10 min in 50 μl denaturation buffer containing 1% sodium dodecyl
sulfate (SDS) and 10 mM dithiothreitol (DTT). The supernatant was equilibrated in 1 mL
wash buffer and HA-tagged HLA-B27:05 molecules were re-immunoprecipitated with anti-
HA coupled to Protein A-agarose beads. Immune complexes were washed once with wash
buffer and treated with Endoglycosidase F1 as described [24].
Western blot analysis
Cell lysates or immune complexes were resolved on 11% sodium dodecyl sulfate (SDS)- poly-
acrylamide gels and transferred onto polyvinylidene fluoride (PVDF) membranes. Proteins
were detected by incubating the membranes with primary and alkaline phosphatase-conju-
gated secondary antibodies, respectively. Protein-antibody complexes were visualized by
5-bromo-4-chloro-3-indolyl-phosphate (BCIP)/nitro blue tetrazolium (NBT) colorimetric
method. For non-reducing gel electrophoresis, cells were incubated with 20 mM solution of
the alkylating agent N-ethylmaleimide (NEM) (Applichem, Darmstadt, Germany) prior to
and during lysis [25]. Immunoprecipitation was performed as described above and immune
complexes were denatured by boiling in the presence of SDS (1%) and dithiothreitol (DTT),
where indicated. To prevent in-gel reduction of disulfide bonds, sample buffer was supple-
mented with NEM. In order to quantify the amount of β2m-bound B27 heavy chains in STF1
and STF1-TAP2 cells, we immunoprecipitated the heterodimeric complexes using mouse
monoclonal anti-human β2m antibody BBM.1. Amount of B27 heavy chains that were readily
associated and co-immunoprecipitated with β2m were analyzed in immunoblotting using
anti-HA antibody. To prevent the dissociation of suboptimally loaded B27 molecules from
β2m in STF cells, 20μM of IRAAPPPLF peptide was added to the cells immediately preceding
the addition of lysis buffer. For specific peptide binding assay, we have added the IRAAPPPK
(Biotin)F peptide to the post-nuclear supernatants of STF cells that were lysed with the native
lysis buffer containing Triton X-100 (1%). Biotinylated proteins were recovered by neutravi-
din-agarose beads (ThermoFisher, Scientific, Waltham, MA, USA). Beads were boiled and
associated proteins were resolved in SDS-PAGE. B27 heavy chains were detected using anti-
HA antibody in immunoblotting.
Thermostability assay
Cells were labeled with 35S-methionine and -cysteine for 7 min as described above and else-
where. Post-nuclear supernatant (lysate) was kept either on ice or in a heat block at different
temperatures (25, 30, 35, 40˚C, respectively) for 10 min. Folded HLA molecules were immuno-
precipitated with W6/32. Next, HA-tagged HLA-B27:05 molecules were isolated from the
supernatant of boiled W6/32 conjugated Protein A beads as described above. The total amount
of W6/32-reactive HLA-B27:05 molecules in the heat-treated lysates was determined by quan-
tifying the 35S signal from the individual samples run on SDS-polyacrylamide gels.
Molecular dynamics (MD) simulations
Coordinates of HLA-B27:05 bound to the high affinity peptide IRAAPPPLF were taken from
a 1.85 Å resolution X-ray crystal structure (PDB ID: 3BP4 [26]). The empty structure was pre-
pared by deleting the corresponding peptide residues from the crystal structure. To model the
disulfide mutant, the residues Y84 and A139 were mutated to cysteine residues and a disulfide
bond was build using the LEAP program in Amber 12 [27]. PROPKA 3.1 [28] was used to
determine protonation states at pH 7. Each complex was placed in an octahedral TiP3 [29]
water box together with ten Na+ and Cl− ions and neutralized with eight counter-ions. The
structures were then subjected to 1500 steps of steepest-descent (SD) energy minimization,
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positionally restrained (25 kcalmol−1 Å−2), and heated from 100 to 300 K. The restraints
were resolved in five steps, and then each complex was equilibrated for 1 ns and simulated
for two independent 50 ns MD simulations. Short-range non-bonded interactions were
taken into account up to a cut-off value of 9 Å. Long-range electrostatic interactions were
treated with the particle mesh Ewald method [30]. The RMSF was measured with the ptraj
program in Amber 12. Visualization of trajectories and preparation of figures were per-
formed using Pymol [31].
Brefeldin A decay
The Brefeldin A (BFA) decay was performed as described previously [8]. BFA was purchased
from AppliChem (Darmstadt, Germany) and used at 10 μg/ml. Briefly, the cells were kept at
25˚C overnight and were moved to 37˚C for 30, 60, 120, and 240 min after addition of BFA. At
the end of the incubation times, cells were harvested by trypsinization and stained according
to the flow cytometry protocol. For the initial time point, cells kept at 25˚C overnight were
used.
Results
Disulfide mutant shows restricted mobility of the F-pocket
Connecting the distal end of the peptide binding domain of murine class I allotype H-2Kb via
C84-C139 disulfide bond improves the conformational stability of the peptide-receptive class
I-β2m heterodimer [13]. Based on this finding, we wanted to know if the same disulfide modi-
fication would help another class I molecule HLA-B27:05 to preserve its structure in the
absence of high-affinity peptides. In analogy to the previously published disulfide mutant of
H-2Kb, we introduced two cysteines at positions 84 (Tyr) and 139 (Ala) of the HLA-B27:05
coding sequence (Fig 1A). Additionally, an influenza hemagglutinin (HA) epitope tag was
attached to the extracellular domain (N terminus). Formation of the disulfide bond is expected
to connect the ends of alpha 1 and alpha 2–1 helices of the B27:05 heavy chain (Fig 1B). We
verified the presence of the additional (third) disulfide bond by detecting the downward shift
in the migration pattern of the non-reduced B27:05-Y84C heavy chain in gel electrophoresis
(Fig 1C). We then examined the structural changes occuring in the peptide binding regions of
peptide-bound and empty wild type B27:05 and empty B27:05-Y84C by molecular dynamics
(MD) simulations. In wild type B27:05, deletion of the peptide resulted in increased flexibility
of the binding region especially in the helices flanking the F-pocket (Fig 1D, middle), whereas
empty B27:05-Y84C (right) was equally stable as wild type B27:05 complexed with peptide
(left). We conclude that the additional C84-C139 disulfide bond confers higher molecular
order to the B27:05 molecule even in the absence of high-affinity peptides.
The disulfide mutant of HLA-B27:05 reaches the cell surface in
TAP2-deficient cells
We compared the cell surface expression of HA-tagged wild type B27:05 and its disulfide
mutant, B27:05-Y84C, with regard to MHC I-specific peptide supply. From STF1 cells, which
are TAP2- and hence peptide-deficient, we generated the peptide-proficient cell line
STF1-TAP2 by lentiviral introduction of the human TAP2 gene. The presence the TAP2 pro-
tein was confirmed in Western blotting (S1A Fig), and its functionality was verified by elevated
endogenous HLA cell surface levels (S1B Fig). We then introduced GFP- and HA-tagged
forms of wild type B27:05and B27:05-Y84C in STF1 and STF1-TAP2 cells and examined cell
surface expression of both constructs by fluorescence microscopy and flow cytometry. Hardly
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any cell surface wild type B27:05 could be detected after staining with anti-HA, while recon-
stitution of human TAP2 led to an approximately ten-fold increase in wild type B27:05 cell
surface expression (Fig 2A, upper row). Cell surface expression of the B27:05-Y84C, in con-
trast, was independent of TAP2 function and peptide supply, since strong cell surface signals
Fig 1. Design and and analysis of molecular flexibility of HLA B27:05 disulfide mutant. (A) Schematic representation of the HLA B27:05 disulfide mutant
expression construct (B27:05-Y84C). A lentiviral expression plasmid containing HLA B27:05 was modified to introduce two cysteine codons at positions 84 and 139
(after signal sequence cleavage) to introduce a disulfide bond in the B27:05 heavy chain. Antibody tag (HA) was introduced to the N terminus following the signal
sequence (SS). (B) Modeling and schematic representation of the 84–139 disulfide bond. Ribbon diagram of B27:05-Y84C (only residues 1 to 182 shown, peptide
omitted from the image) indicates to two cysteines (represented as sticks) at positions 84 and 139 (arrows) located at α1 and α2–1 domains of the heavy chain,
respectively. The structure was predicted by Disulfide by Design v2.12 [32] from the original PDB file 1HSA. (C) Confirmation of disulfide bond formation. Lysates of
STF1-B27:05 cells were subjected to immunoprecipitation with anti-HA, and the proteins were separated under reducing (+ DTT) and non-reducing (- DTT)
conditions. The proteins were visualized using anti-HA antibody in immunoblotting. In the absence of DTT, B27:05-Y84C (lane 4) runs slightly faster than wild type
B27:05 (lane 3) due to the additonal disulfide bond that renders the protein more compact. First and last lanes show the 40 kDa protein from the size marker. (D)
Flexibility of the HLA B27:05 binding groove in MD simulations. A peptide-free and 84–139 disulfide linked versions of HLA B27:05 were derived from the crystal
structure of wild type B27:05 complexed with the cathepsin A-derived high-affinity peptide IRAAPPPLF (PDB: 3BP4). The flexibilities of the peptide binding regions
were calculated as the root mean square fluctuation (RMSF) of the individual alpha carbon atoms for molecular dynamics simulations that were run for 250 ns. Values
are depicted as a blue to red color spectrum on cartoon representations. In the vicinity of the C84-C139 disulfide bond, the dynamics of empty B27:05-Y84C (right)
equal those of peptide-bound wild type B27:05 (left) while empty B27:05 shows a higher flexibility in that region (middle).
https://doi.org/10.1371/journal.pone.0200811.g001
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Fig 2. The disulfide mutant of HLA B27:05 travels to the cell surface in TAP2-deficient cells. (A) Cell surface expression of wild type
B27:05 and B27:05-Y84C by microscopy. STF1 and STF1-TAP2 cells were transiently transfected with C-terminally GFP-tagged B27:05 and
B27:05-Y84C. Cells were fixed and stained using monoclonal anti-HA antibody and anti-mouse IgG conjugated with Cy3, sequentially, and
observed with a confocal laser scanning microscope. In TAP2-deficient (and hence peptide-deficient) STF1 cells, wild type B27:05 was primarily
found in the tubular ER (green), and no surface stain was detected with anti-HA (red, upper row, left), whereas B27:05-Y84C was located in the
ER, the Golgi (arrow), and at the cell surface (left, lower row) and displayed strong surface stain with anti-HA antibody. In peptide-proficient
STF1-TAP2 cells, the constructs were both distributed similarly, accompanied by strong cell surface HA signals (right). (B) Cell surface
expression of wild type B27:05 and B27:05-Y84C by flow cytometry. Cells expressing either B27:05 (blue) or B27:05-Y84C (orange) were
stained with anti-HA and anti-mouse IgG conjugated with AlexaFluor-488 and subjected to flow cytometry. Surface staining intensities of each
cell line are displayed as histograms. The grey curve in both histograms shows the background signal obtained without using primary antibody.
(C) Comparison of cell surface expression of wild type B27:05 and B27:05-Y84C in STF1 and STF1-TAP2 cells. The scatter plot
(mean ± standard deviation, n = 8, n = 6) shows the distribution of individual measurements (black dots) of cell surface staining intensities of
B27:05 and B27:05-Y84C in STF1 and STF1-TAP2 cells (: Significant difference, P<0.001, two-tailed t-test, NS: not significant). In
TAP2-deficient STF1 cells, surface expression of B27:05-Y84C was about five times higher than for the wild type construct (left), but this
difference nearly disappeared in TAP2-proficient cells (right).
https://doi.org/10.1371/journal.pone.0200811.g002
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could be observed in both TAP2-proficient and TAP2-deficient STF1 cells (Fig 2A, lower row).
Flow cytometry data obtained by staining the cells with anti-HA confirmed the strong depen-
dence of wild type B27:05 cell surface expression on optimal peptide supply, while the cell sur-
face expression of B27:05-Y84C was not impaired in TAP2-deficient STF1 cells (Fig 2B and
2C). Repetition of the flow cytometry experiment with the anti-HLA monoclonal antibody W6/
32 revealed the same results (S1C and S1D Fig), which parallel the increase in the surface expres-
sion of endogenous HLA Class I molecules in non-B27 transformed STF1-TAP2 cells (S1B Fig).
We thus conclude that B27:05-Y84C can overcome the anterograde intracellular quality control
and reach the cell surface in the absence of peptides supplied by the TAP transporter.
Wild type and disulfide mutant of HLA-B27:05 are equally stable at the
surface of TAP-deficient cells
We have previously shown that stabilization of the F pocket via the C84-C139 disulfide linkage
leads to a dramatic increase in the surface lifetime of H-2Kb in TAP-deficient cells [13]. In the
light of those findings, we wanted to find out if the increased levels of B27:05-Y84C at the cell
surface were also due to the resistance of the stabilized molecule to endocytic degradation. For
this, we followed the disappearance of both HA-tagged wild type B27:05 and B27:05-Y84C
from the cell surface within four hours after Brefeldin A (BFA) addition to the cells. At 37˚C,
levels of wild type B27:05 are very low at the surface of TAP2-deficient cells (Fig 2). To gener-
ate a sizeable pool of molecules at the cell surface, we therefore incubated the cells at lower
temperature (25˚C) overnight [33]. This treatment led to a nearly fourfold increase in the sur-
face levels of wild type B27:05 (S2A Fig). At the beginning of the experiment, B27:05-Y84C
still showed significantly higher cell surface levels than the wild type in TAP2-deficient cells
(Fig 3A, left) since B27:05-Y84C levels also increased after the 25˚C incubation (data not
shown). The surface signal decreased drastically over time for both variants, although
B27:05-Y84C cell surface levels after four hours of decay (time point 240 min) still slightly
exceeded those of the wild type before BFA treatment (time zero). To better compare the data
for wild type B27:05 and B27:05-Y84C, we normalized all measurement values to the values
detected at time point zero and found that both constructs disappeared from the cell surface at
similar rates in TAP2-deficient STF1 cells (Fig 3B, left). In peptide-proficient STF1-TAP2 cells,
both variants were found to be stable at the cell surface for at least four hours (Fig 3A, right),
but the B27:05-Y84C signal started to decrease after one hour of decay and went down to
approximately 70% of the starting level at time point 240 min, indicating that the disulfide
mutant has a reduced lifetime at the cell surface compared to the wild type protein (Fig 3B,
right). We conclude that while B27:05-Y84C is more abundant than the wild type B27:05 at
the cell surface at any time, increased molecular stability of the B27:05-Y84C mutant does not
contribute to the dynamics of B27:05 endocytosis.
Disulfide-linked HLA-B27:05 traffics faster than the wild type form in
TAP2-deficient cells
The surprising finding that the increased cell surface level of B27:05-Y84C in STF1 cells was
not influenced by endocytosis kinetics then prompted us to investigate the folding and antero-
grade intracellular transport kinetics of both proteins. For this, we followed the biochemical
maturation of the HA-tagged wild type B27:05 and B27:05-Y84C along the secretory path-
way in peptide-deficient STF1 and peptide-proficient STF1-TAP2 cells. Fig 4A shows the
results of pulse-chase analysis and Endo F1 digest, revealing that a small proportion of the wild
type B27:05 molecules progressed beyond the cis-Golgi within 60 min after synthesis (deter-
mined by the Endo F1-resistant bands) in peptide-deficient STF1 cells (upper panel, left), but
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within the next two hours (time points 120 and 240 min) the protein nearly disappeared, indi-
cating rapid degradation (Fig 4C, left). In contrast, almost all of newly synthesized
B27:05-Y84C has already travelled beyond the cis-Golgi within 30 min after chase in STF1
cells (Fig 4A, upper panel, right). The increasing amount of W6/32-reactive protein indicates
Fig 3. Wild type and disulfide mutant of HLA B27:05 are equally stable at the cell surface. (A) Brefeldin (BFA) A decay. Cell surface levels of B27:05 and
B27:05-Y84C were detected by staining STF1 (left) and STF1-TAP2 cells (right) with anti-HA. Cells were harvested and stained at the times indicated, representing the
duration of treatment with BFA. For each sample, the mean fluorescence intensity value recorded by the flow cytometer is depicted on the graph. (B) Averaged decay
from the cell surface. The graph shows the average cell surface levels normalized to the values detected at time point zero (SEM, n = 4). The value for time point zero was
set to 100% and the following values were depicted as its percentage. In peptide-deficient STF1 cells (left), both constructs show similar cell surface lifetimes, whereas in
peptide-proficient STF1-TAP2 cells (right), B27:05-Y84C is slightly less stable at the cell surface than the wild type protein.
https://doi.org/10.1371/journal.pone.0200811.g003
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Fig 4. The disulfide mutant of HLA B27:05 shows accelerated anterograde transport and a longer lifetime than
the wild type form in TAP2-deficient cells. (A) Pulse-chase analysis and Endo F1 resistance. STF1 (upper panel) and
STF1-TAP2 cells (lower panel) expressing HA-tagged wild type B27:05 and B27:05-Y84C were labeled with 35S-
methionine/-cysteine and were chased for the times indicated. HA-tagged molecules were isolated from lysates by
sequential immunoprecipitation using W6/32 and anti-HA antibodies, respectively. Where indicated, immunoisolates
were treated with Endoglycosidase F1. (B) Quantification of Endo F1 resistance. The total band intensity was
calculated for each lane, and the proportion of the Endo F1-resistant band was depicted as percentage of the total. The
disulfide mutant B27:05-Y84C reaches Endo F1 resistance faster than the wild type form in peptide-deficient STF1
cells (left), whereas in peptide-proficient STF1-TAP2 cells, both constructs show similar glycan maturation rates
Stabilized HLA-B27 reaches the cell surface without peptide
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that the folding of B27:05-Y84C continued until the end of the 60 min chase time point, and
both the Endo F1-resistant and the Endo F1-sensitive forms which could be detected through-
out the chase period indicated a longer lifetime for the disulfide mutant than for the wild type
form (Fig 4C, left). In peptide-proficient STF1-TAP2 cells, however, both constructs trafficked
rapidly towards the cell surface and accumulated in their Endo F1-resistant forms during the
chase period (Fig 4A, lower panel, and Fig 4B, right). The steady increase of a W6/32-reactive
signal indicates that the folding of both proteins continued throughout the chase (Fig 4C,
right). These results support the previous observations that B27:05-Y84C can escape protein
quality control in the early secretory pathway, whereas wild type B27:05 is degraded intracel-
lularly when optimal peptides are not present.
In the absence of optimal peptide, the disulfide mutant of HLA-B27:05 is
more thermostable and structurally more ordered than the wild type
We next sought to understand the molecular mechanism underlying the superior ER-surface
transport competence of HA-tagged B27:05-Y84C in cells where TAP complex is not func-
tional. We hypothesized that one reason why B27:05-Y84C could escape quality control
checkpoints in the early secretory pathway might lie in its ability to preserve a folded confor-
mation in the absence of TAP-dependent peptides. To compare the relative conformational
stability of wild type B27:05 and B27:05-Y84C, we determined the amounts of W6/32-reac-
tive proteins in cell lysates that were gradually heated up to 40˚C. It is known that the amount
of W6/32-positive HLA-B decreases drastically in heated lysates when tapasin is absent and,
hence, peptide loading onto HLA-B is impaired [34]. We thus hypothesized that B27:05-
Y84C would display a different heat sensitivity pattern that the wild type form, especially in
TAP2-deficient STF1 cells. In peptide-proficient STF1-TAP2 cells, both constructs remained
rather stable up to a temperature of 40˚C confirming that the TAP-mediated supply of optimal
peptides supported the folded conformation of HLA molecules in detergent lysates (Fig 5A,
lower panel). In peptide-deficient STF1 cells, however, the amount of W6/32-reactive wild
type B27:05 remained stable only until 30˚C and started to drastically decrease from 35˚C
onwards, whereas higher amounts of B27:05-Y84C were detected in lysates heated up to 35
and 40˚C (Fig 5A, upper panel). To be able to illustrate the difference in the thermal stabilities
of both constructs in TAP2-deficient STF1 cells more clearly, we calculated the 35˚C / 4˚C sig-
nal ratio, which clearly demonstrated the higher thermal stability of the disulfide mutant versus
wild type B27:05 at 35˚C in TAP2-deficient STF1 cells (Fig 5B, left). In peptide-proficient
STF1-TAP2 cells, both constructs showed comparable thermal stabilities at 35˚C (Fig 5B,
right). To determine if the higher thermal stability of the heterodimer is due to the increased
affinity between the B27:05-Y84C heavy chain and β2m, we then isolated and quantified the
amount of β2m -associated B27:05 heavy chains from cell lysates. In TAP-deficient STF1 cells,
immunoprecipitation with human β2m-specific monoclonal antibody BBM.1 yielded plenty of
B27:05-Y84C heavy chains while amount of BBM.1-reactive wild type B27:05 complexes
remained below detection level (Fig 5C). We were able to recover low amounts of wild type
B27:05 heavy chains only in the presence of B27:05-specific peptide (IRAAPPPLF, IF9) dur-
ing lysis. As expected, similar amounts of wild type and mutant B27:05 heavy chains were
(right). (C) Folding kinetics calculated by W6/32 reactivity. The total amounts of protein (Endo F1-sensitive plus Endo
F1-resistant bands) were calculated for each lane, and the intensities were depicted as percentage of the total intensity
of the band from time point zero. In peptide-deficient STF1 cells, the amount of wild type B27:05 remains stable
during the first hour of chase and starts to decline rapidly, whereas the amount of B27:05-Y84C increases steadily
within the first hour, and degradation of this molecule occurs much more slowly (left). In peptide-proficient
STF1-TAP2 cells, the production and folding of wild type B27:05 and B27:05-Y84C are comparable (right).
https://doi.org/10.1371/journal.pone.0200811.g004
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isolated from TAP-proficient cells (Fig 5C, lanes STF1-TAP2), indicating a reduction in the
β2m –affinity of the wild type B27:05 in the absence of high-affinity peptide ligands. We did
not observe an increase in the amount of BBM.1-reactive B27:05-Y84C heterodimers after
having added the high affinity IF9 peptide to the lysates (compare lanes 2 and 4 in Fig 5C).
This prompted us to investigate if the B27:05-Y84C was able to bind the peptide in the first
place. We therefore isolated the peptide-bound B27:05 molecules through immunoprecipita-
tion of the B27:05-biotinylated IF9 complexes with streptavidin. We recovered considerably
more B27:05-Y84C bound to biotinylated IF9 than the wild type (Fig 5D), indicating the
Fig 5. B27:05-Y84C is more resistant to thermal denaturation and structurally more ordered in the peptide-receptive state. (A) Thermal stability assay. STF1
(upper panel) and STF1-TAP2 cells (lower panel) expressing HA-tagged wild type B27:05 and B27:05-Y84C were pulse-labeled with 35S-methionine/-cysteine for 7
min and then lysed. Detergent lysates were incubated at the temperatures indicated for 10 min prior to sequential immunoprecipitation with W6/32 and anti-HA,
respectively. (B) Quantification of thermal stability. Band intensities from lanes representing 4 and 35˚C were calculated for the individual samples. Thermal stability of
the constructs is calculated and displayed in a bar chart as the ratio of the 35˚C signal over the 4˚C signal from W6/32 immunoprecipitation (SEM, n = 3). Wild type
B27:05 shows a decrease in thermal stability in the absence of TAP2 (left) whereas B27:05-Y84C is equally stable in STF1 and STF1-TAP2 cells. (C) β2m affinity
measurement. Human β2m was immunoprecipitated from cell lysates using BBM.1 antibody. Co-immunoprecipitated B27:05 heavy chains were identified by western
blotting using HA antibody (upper row). Where indicated, a high-affinity ligand for B27:05 (IRAAPPPLF) was added to the lysate prior to immunoprecipitation.
STF1-TAP2 cells were used as a positive control for BBM.1 immunoprecipitation. Last lane (CTRL) indicates STF1 cells that do not express B27:05. Equal amount of
lysate (2% of total) was loaded on a separate gel as a loading control (lower row). B27:05 heavy chains were detected using anti-HA in immunoblotting (IB). (D) Peptide
binding to B27:05. Biotinylated IRAAPPPKF peptide was added to the cells (where indicated) at the point of lysis, and complexed proteins were isolated using
streptavidin-conjugated agarose beads. Associated B27:05 heavy chains were detected using anti-HA antibody in immunoblotting. Last two lanes are loading controls
from the lysates (2% of total).
https://doi.org/10.1371/journal.pone.0200811.g005
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ability of the Y84C mutant to preserve a stable and peptide-receptive conformation in TAP-
deficient cells.
Discussion
Human and mouse cells are capable of recognizing MHC class I molecules that have failed to
load high-affinity peptides and of preventing them from reaching the cell surface in order to
avoid binding of extracellular peptides. In search of a molecular explanation for the differences
between class I molecules loaded with high-affinity peptides and suboptimally loaded class I
molecules bound to low-affinity peptides, we have discovered a region in the class I heavy
chain that is most likely targeted by the cellular quality control systems. This region, comprised
of the amino acids that form the F pocket, becomes highly flexible when a peptide fails to inter-
act with the heavy chain via its C terminus [9,10]. In the presence of a high-affinity peptide,
the flexibility of the F pocket region is reduced by the increasing number of hydrophobic inter-
actions as well as hydrogen bonds between the side chains of the peptide and the F pocket resi-
dues [35]. We demonstrated that the immobilization of the F pocket by fixing the ends of the
α1 and α2−1 helices was sufficient to stabilize the murine MHC class I allotype H-2Kb (as well
as another murine allotype H-2Db, unpublished data) such that it could escape ER quality con-
trol [13]. Since the residues involved in this artificial fixation (tyrosine 84 and alanine 139) are
highly conserved for classical MHC Class I molecules among species, we decided to investigate
whether the disulfide mutation would have the same effect on HLA-B27:05, a human class I
subtype that was previously shown to have low intrinsic stability [36] and tendency to form
unusual heavy chain configurations [37].
First, we used comparative MD simulations of HLA-B27:05, we showed reduced flexibility
of the residues in the F pocket for the empty Y84C mutant similar to that of the peptide-bound
HLA-B27:05. Due to high computational demand, MD simulations are limited in predicting
and analyzing conformational changes in proteins only within a nanosecond-timescale, which
does not reflect all possible alterations that are taking place in class I molecules, which have
lost their peptide ligands. Nevertheless, our results are consistent with previous MD simula-
tions (nano/microsecond-timescale) of human and murine allotypes [38–40] and suggest that
the 84-139 disulfide bond restrains the F-pocket flexibility similar to the binding of the C-ter-
minal residue of the bound peptide.
Next, we showed that cell surface expression of HA-tagged wild type HLA-B27:05 is
dependent on peptides delivered to the ER via the TAP transporter since it is intracellulary
retained in TAP2-deficient STF1 cells (Fig 2). The steady state levels were restored by the
introduction of the TAP2 gene (STF1-TAP2 cells), indicating that the reduced cell surface
expression of the wild type protein is due to the lack of high-affinity peptides in the ER. The
disulfide mutant B27:05-Y84C, however, was readily detected at the surface of STF1 cells,
indicating the ability of this molecule to bypass intracellular retention mechanisms that apply
to empty or suboptimally loaded MHC class I molecules. This observation reinforces the sug-
gestion that a general mechanism exists in cells that surveys the flexibility of the helices in the
peptide binding domain of class I heavy chains as an indicator of optimal peptide selection.
Similar levels of wild type B27:05 and B27:05-Y84C at the surface of STF1-TAP2 cells (Fig 2)
and pull-down experiment using B27:05-specific peptide (Fig 5D) imply that the disulfide
mutant can bind peptides and can present them at the cell surface. Despite its ability to bind
high-affinity peptide (Figs 5D and S2D), B27:05-Y84C disappeared more quickly from the
surface of TAP2-proficient cells than the wild type B27:05 (Fig 3). Loss of the conformation
recognized by W6/32 antibody in B27:05-Y84C despite the presence of optimal peptides is
supported by our observation that lesser amounts of β2m-bound Y84C heavy chains can be
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recovered from TAP-proficient cells (Fig 5C, compare lanes 4 and 6). This contrasts with our
previous biochemical and cell biological analyses that show that the disulfide mutant of H-2Kb
is equally or only slightly less stable than the wild type in peptide-bound form [13]. It is plausi-
ble to suggest that the hydrogen bonds between peptide C terminus and tyrosine at position 84
contributes differentially to the stability of the trimers among allotypes and peptides, but their
absence reduces the overall stability of the peptide-MHC I complex in general. Other residues
involved in interactions with the peptide (such as N97) might also drive B27:05 to accomo-
date a more open conformation of the F pocket, [41,42] which is not possible for B27:05-
Y84C. Since the relative molecular stability of B27:05-Y84C is much higher than the wild type
in TAP-deficient cells (higher β2m affinity and ability to bind peptides, Figs 5 and S2D), it can
be speculated that the mutant attains a different (and probably much more stable) conforma-
tion in the ER when it is devoid of peptide. This is supported by our finding that the B27:05-
Y84C mutant, when newly synthesized, is more resistant to thermal denaturation (loss of W6/
32 epitope) than wild type B27:05 (Fig 5A) and that it continues to gain increasing recogni-
tion by W6/32 during its folding in STF1 cells (Fig 4).
Surprisingly, the improvements in the binding strength between the heavy chain and β2m
via C84-C139 disulfide linkage do not contribute to the lifetime of B27:05-Y84C at the cell
surface. This interesting observation helps us understand the consequences of the changes in
the conformational states of class I molecules during their transport inside the cell and their
residence at the cell surface. Combined with our previous observations from disulfide muta-
tions from murine class I allotypes H-2Kb and H-2Db, we propose that preservation of the
heavy chain-β2m heterodimer is sufficient for class I molecules to exit early secretory pathway.
This rule applies to HLA-B27:05, even though this particular class I molecule was previously
shown to have an exceptionally low affinity for β2m [36]. HLA-B27:05 was also shown to
require relatively long time for folding [43–45]. Our intracellular transport studies have
revealed that the stably folded state of B27:05-Y84C manifests itself in a faster maturation rate
of the protein inside the cell (Fig 4). In the same cells, B27:05-Y84C is increasingly recognized
by W6/32 within the first hour of chase, suggesting also slow folding but more efficient ER
exit. The slight decrease of W6/32-reactive amounts of B27:05-Y84C after two hours of chase
(Fig 4C, left) are possibly due to the endocytic degradation of the molecules that have reached
the cell surface. The drastic reduction in the amount of W6/32-reactive wild type B27:05 after
two hours of chase in TAP2-deficient STF1 cells is on the other hand most likely due to ER-
associated degradation (ERAD) in the absence of peptide [46]. The lack of HA- or HC-10-pos-
itive wild type B27:05 in TAP-deficient cell line STF1 (S2C Fig) also confirms the require-
ment of cell surface transport of B27:05 for the generation of β2m-free heavy chains and
disulfide linked structures arising from them [36,37].
In cells that lack components of the peptide loading complex, class I molecules are retained
in the early secretory pathway [43], and low-stability heterodimers and trimers that have
escaped early quality control steps are removed from the cell surface. We observe the outcome
of the cell surface quality control mechanism by the disappearance of peptide-receptive or sub-
optimally loaded heterodimers from the surface that were brought up by incubating cells at
low temperature [33,47]. We suggest that this quality control mechanism at the cell surface
surveys primarily the binding strength of class I heavy chain and β2m, rather than the occu-
pancy of class I molecules with peptides. Indeed, surface lifetimes of both wild type and disul-
fide mutant of B27:05 were restored in STF1 cells when the BFA decay was performed at
25˚C (S2B Fig). To our surprise, the enhanced structural stability of the peptide-receptive het-
erodimers of B27:05-Y84C (Fig 5C) is insufficient in rescuing the mutant from endocytic
degradation. This suggests that the Y84C-heterodimers dissociate shortly after their arrival at
the cell surface. Supporting this assumption, we observe elevated levels of HC-10 positive
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heavy chains of B27:05-Y84C at the surface of both STF1 cells (S2C Fig). The behaviour of
B27:05-Y84C in TAP-deficient cells might be considered comparable to the phenotype of AS-
related B27:05 subtypes in conjunction with non-synonymous ERAP1 polymorphisms [48–
51]. While B27:05 fails to exit the early secretory pathway in the absence of peptides depen-
dent on TAP, it should able to breach the first step of quality control and arrive at the surface
when ERAP1 function is impaired. In line with this hypothesis, N-terminally elongated 11–13
mer peptides were eluted from B27:05 in an ERAP1-silenced model system [52], underlining
the ability of this class I subtype to bind non-canonical peptide motifs [53]. Several indepen-
dent studies showed that the formation of HLA-B27 free heavy chains at the surface is highly
susceptible to changes in ERAP1 activity (achieved by silencing of ERAAP or by the overex-
pression of the wild type or mutants or chemical inhibition of the enzyme) in model cell lines
as well as in cells from AS-patients carrying ERAP1 polymorphisms [54–56]. Not all ERAP
polymorphisms that are found in AS-patients result in increased levels of β2m-free B27 heavy
chains [56], although functional impairment of this enzyme clearly alters the pool of peptides
presented on HLA-B27 [48–52]. This implicates the requirement of an additional factor that
controls the release of suboptimally loaded B27 molecules to the cell surface. In some
instances, loss of ERAP1 activity leads to an increase in β2m-free B27:05 in ERAP1 knock-
down cell models, while surface HC-10 levels of other tested HLA-B allotypes remained
unchanged [54,55]. Those HC-10 molecules are most likely to be removed from the cell surface
efficiently, however, they can possibly be stabilized against endocytic degradation by the for-
mation of an intermolecular disulfide bond, mediated by the unpaired cysteine at position 67.
When formed at the surface, such heavy chain dimers of B27:05 can react with killer cell
immunoglobulin-like receptors (KIR) in a peptide-independent fashion [57] and promote dif-
ferentiation of pathogenic Th17 cells expressing the particular B27:05-homodimer reactive
KIR-3DL2 [58]. Empty B27:05-Y84C at the surface of antigen presenting cells or multimers
made of recombinant B27:05-Y84C can be a useful tool for the detection and functional anal-
yses of such alloreactive cells in patients.
Our study confirms the presence of a quality control mechanism in the early secretory path-
way that surveys the flexibility of the F pocket of class I molecules in general. The artificially
stabilized mutants of human and murine MHC molecules are useful tools to delineate protein
folding and monitoring in cells. It is also noteworthy to mention that the disulfide mutants of
class I are potentially powerful tools for diagnostic and therapeutic approaches involving
MHC-multimers and in vitro T-cell activation.
Supporting information
S1 Fig. HLA cell surface expression after TAP2 reconstitution in STF1 cells. (A) TAP2
expression is restored in STF-TAP2 cells. The TAP2 gene was introduced into STF1 cells by
viral transduction (generating STF1-TAP2 cells), and the expression of TAP2 was verified
western blotting. Lysates of STF1 and STF-TAP2 cells were probed for TAP2 with the mono-
clonal antibody 429.3. Full length TAP2 could only be detected in STF-TAP2 cells migrating
slightly more slowly than the 72 kDa band of the molecular marker. Calnexin was used as a
loading control (upper band at 90 kDa). The asterisk marks an unspecific band detected in
both lysates.
(B) TAP2 is fully functional in STF1-TAP2 cells. TAP function was confirmed by measuring
the surface levels of endogenous HLA levels by using the monoclonal anti-HLA antibody, W6/
32 and anti-mouse IgG conjugated to AlexaFluo-488 in flow cytometry. In peptide-deficient
STF1 cells, only low cell surface expression of endogenous HLA molecules could be detected
(dashed line), in peptide-proficient STF1-TAP2 cells, however, the surface expression was
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strongly enhanced (solid line) confirming functionality of the reconstituted TAP transporter.
(C) Cell surface expression of B27:05 and B27:05-Y84C. Cells were stained with W6/32 and
anti-mouse IgG conjugated with AlexaFluor-488 and subjected to flow cytometry. Surface sig-
nal intensities from B27:05 (blue) and B27:05-Y84C (orange) are displayed as histograms.
Grey lines indicate cells that were stained only with the secondary antibody.
(D) The scatter plot (mean ± standard deviation, n = 3) shows individual cell surface W6/32 mea-
surements in STF1 and STF-TAP2 cells (black dots). In TAP2-deficient STF1 cells, surface expres-
sion of B27:05-Y84C was about three times higher than for the wild type construct (left) whereas
in TAP2-proficient cells, both constructs showed comparable cell surface expression (right).
(TIF)
S2 Fig. Surface lifetimes of wild type and disulfide mutant of HLA B27:05 can be rescued
at the cell surface of TAP2-deficient cells at 25˚C. (A) Wild type B27:05 reaches the cell sur-
face of TAP2-deficient cells at 25˚C. Peptide-deficient STF1 cells expressing wild type B27:05
were kept at 25 and 37˚C, respectively, stained with anti-HA and anti-mouse IgG conjugated
with AlexaFluor-488, and subjected to flow cytometry. Wild type B27:05 shows a much higher
cell surface expression at 25 (blue line) than at 37˚C (orange line). The grey curve in both his-
tograms shows the background signal without primary antibody. Quantification of surface sig-
nals obtained at 25˚C (blue) and 37˚C (black, set to one) revealed a 4-fold increase in surface
levels of wild type B27:05 (scatter plot with mean ± standard deviation, right).
(B) Averaged BFA decay from the cell surface at 25˚C. STF1 cells were kept at 25˚C and surface
levels of B27:05 and B27:05-Y84C were detected by staining STF1 cells with anti-HA. Cells
were harvested and stained at the times indicated representing the duration of treatment with
Brefeldin A. The graph shows the cell surface levels normalized to the values detected at time
point zero (SEM, n = 4), which was set to 100% with the following values depicted as its per-
centage. Both constructs show similar residence times at the cell surface when incubated at
25˚C.
(C) B27:05 free heavy chains on the surface of TAP-deficient cells. Scatter plot
(mean ± standard deviation, n = 2,4,4) shows the levels of class I free heavy chains detected by
HC-10 antibody at the surface of STF1, STF1-B27:05 and STF1-B27:05-Y84C cells at 37˚C,
respectively. Acquired staining intensities from individual experiments were normalized to
wild type B27:05 levels. B27:05-Y84C reveals approximately 4-fold higher more free heavy
chains that the wild type protein.
(D) Peptide binding to B27:05 at the cell surface. STF1 cells expressing either B27:05-WT or
B27:05-Y84C were incubated with 20 μM of the B27:05-specific peptide IRAAPPPLF over-
night (black bars). Amount of B27:05 molecules were detected with anti-HA antibody and
displayed in comparison with the samples without peptide addition (grey bars). IRAAPPPLF
can bind and stabilize B27:05-Y84C molecules that have reached cell surface whereas surface
levels of B27:05-WT cannot be improved by the peptide.
(TIF)
Acknowledgments
We thank our colleagues for reagent donations and Uschi Wellbrock for constant and excel-
lent technical support. The work was supported by the Deutsche Forschungsgemeinschaft
(DFG), grant SP 583/8-1 to SSp.
Author Contributions
Conceptualization: Zeynep Hein, Sebastian Springer.
Stabilized HLA-B27 reaches the cell surface without peptide
PLOS ONE | https://doi.org/10.1371/journal.pone.0200811 August 2, 2018 16 / 20
Data curation: Zeynep Hein, Britta Borchert, Esam Tolba Abualrous.
Formal analysis: Zeynep Hein, Esam Tolba Abualrous.
Investigation: Esam Tolba Abualrous.
Writing – original draft: Zeynep Hein, Britta Borchert, Esam Tolba Abualrous, Sebastian
Springer.
Writing – review & editing: Zeynep Hein, Britta Borchert, Sebastian Springer.
References
1. Wearsch PA, Cresswell P. The quality control of MHC class I peptide loading. Current Opinion in Cell
Biology. 2008. https://doi.org/10.1016/j.ceb.2008.09.005 PMID: 18926908
2. Wright CA, Kozik P, Zacharias M, Springer S. Tapasin and other chaperones: models of the MHC class
I loading complex. Biol Chem. 2004; 385: 763–778. https://doi.org/10.1515/BC.2004.100 PMID:
15493870
3. Hulpke S, Tampe´ R. The MHC I loading complex: A multitasking machinery in adaptive immunity.
Trends in Biochemical Sciences. 2013. https://doi.org/10.1016/j.tibs.2013.06.003 PMID: 23849087
4. Hsu VW, Yuan LC, Nuchtern JG, Lippincott-Schwartz J, Hammerling GJ, Klausner RD. A recycling
pathway between the endoplasmic reticulum and the Golgi apparatus for retention of unassembled
MHC class I molecules. Nature. 1991; https://doi.org/10.1038/352441a0 PMID: 1861723
5. Garstka M, Borchert B, Al-Balushi M, Praveen P V, Kuhl N, Majoul I, et al. Peptide-receptive major histo-
compatibility complex class I molecules cycle between endoplasmic reticulum and cis-Golgi in wild-type
lymphocytes. J Biol Chem. 2007; 282: 30680–30690. https://doi.org/10.1074/jbc.M701721200 PMID:
17656363
6. Howe C, Garstka M, Al-balushi M, Ghanem E, Antoniou AN, Fritzsche S, et al. Calreticulin retrieves
suboptimally loaded MHC class I molecules from the Golgi apparatus.
7. MahmutefendićH, BlagojevićG, Tomasˇ MI, KučićN, Lučin P. Segregation of open Major Histocompati-
bility Class i conformers at the plasma membrane and during endosomal trafficking reveals conforma-
tion-based sorting in the endosomal system. Int J Biochem Cell Biol. 2011; https://doi.org/10.1016/j.
biocel.2010.12.002 PMID: 21176792
8. Montealegre S, Venugopalan V, Fritzsche S, Kulicke C, Hein Z, Springer S. Dissociation of beta-2
microglobulin determines the surface quality control of the MHC class I molecules. FASEB. 2015; 29:
2780–2788. https://doi.org/10.1096/fj.14-268094 PMID: 25782992
9. Sieker F, Springer S, Zacharias M. Comparative molecular dynamics analysis of tapasin-dependent
and -independent MHC class I alleles. Protein Sci. Wiley Online Library; 2007; 16: 299–308. https://doi.
org/10.1110/ps.062568407 PMID: 17242432
10. Sieker F, Straatsma TP, Springer S, Zacharias M. Differential tapasin dependence of MHC class I mole-
cules correlates with conformational changes upon peptide dissociation: A molecular dynamics simula-
tion study. Mol Immunol. 2008; https://doi.org/10.1016/j.molimm.2008.06.009 PMID: 18639935
11. Glithero A, Tormo J, Doering K, Kojima M, Jones EY, Elliott T. The crystal structure of H-2Dbcomplexed
with a partial peptide epitope suggests a major histocompatibility complex class I assembly intermedi-
ate. J Biol Chem. 2006; 281: 12699–12704. https://doi.org/10.1074/jbc.M511683200 PMID: 16478731
12. Abualrous ET, Fritzsche S, Hein Z, Al-balushi MS, Reinink P, Boyle LH. F pocket flexibility influences
the tapasin dependence of two differentially disease-associated MHC Class I. 2015; 1248–1257.
https://doi.org/10.1002/eji.201445307 PMID: 25615938
13. Hein Z, Uchtenhagen H, Abualrous ET, Saini SK, Janßen L, Van Hateren A, et al. Peptide-independent
stabilization of MHC class I molecules breaches cellular quality control. J Cell Sci. 2014; 127: 2885–97.
https://doi.org/10.1242/jcs.145334 PMID: 24806963
14. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DCO, Sturrock RD. ANKYLOSING SPONDYLI-
TIS AND HL-A 27. Lancet. 1973; https://doi.org/10.1016/S0140-6736(73)91360-3
15. Brewerton DA, Nicholls A, Caffrey M, Walters D, James DCO. ACUTE ANTERIOR UVEITIS AND HL-A
27. Lancet. 1973; https://doi.org/10.1016/S0140-6736(73)91090-8
16. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High Association of an HL-A Antigen, W27, with
Ankylosing Spondylitis. N Engl J Med. 1973; https://doi.org/10.1056/NEJM197304052881403 PMID:
4688372
Stabilized HLA-B27 reaches the cell surface without peptide
PLOS ONE | https://doi.org/10.1371/journal.pone.0200811 August 2, 2018 17 / 20
17. Chen B, Li J, He C, Li D, Tong W, Zou Y, et al. Role of HLA-B27 in the pathogenesis of ankylosing spon-
dylitis (Review). Mol Med Rep. 2017; 15: 1943–1951. https://doi.org/10.3892/mmr.2017.6248 PMID:
28259985
18. Penttinen MA, Ekman P, Granfors K. Non-antigen presenting effects of HLA-B27. Curr Mol Med. 2004;
https://doi.org/10.2174/1566524043479275
19. De La Salle H, Hanau D, Fricker D, Urlacher A, Kelly A, Salamero J, et al. Homozygous human TAP
peptide transporter mutation in HLA class I deficiency. Science (80-). 1994; https://doi.org/10.1126/
science.7517574
20. Zimmer J, Donato L, Hanau D, Cazenave JP, Moretta A, Tongio MM, et al. Inefficient protection of
human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA
class I expression. Eur J Immunol. 1999; https://doi.org/10.1002/(SICI)1521-4141(199904)
29:04<1286::AID-IMMU1286>3.0.CO;2-L
21. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, et al. Production of monoclonal
antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic
analysis. Cell. 1978; https://doi.org/10.1016/0092-8674(78)90296-9
22. Brodsky FM, Bodmer WF, Parham P. Characterization of a monoclonal anti-beta 2-microglobulin anti-
body and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur J
Immunol. 1979; 9: 536–545. https://doi.org/10.1002/eji.1830090709 PMID: 91522
23. Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams DA. Colocalization of retrovirus and target
cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nature Medi-
cine. 1996. https://doi.org/10.1038/nm0896-876
24. Fritzsche S, Springer S. Pulse-chase analysis for studying protein synthesis and maturation. Curr Pro-
toc Protein Sci. 2014; https://doi.org/10.1002/0471140864.ps3003s78 PMID: 25367008
25. Kienast A, Preuss M, Winkler M, Dick TP. Redox regulation of peptide receptivity of major histocompati-
bility complex class I molecules by ERp57 and tapasin. Nat Immunol. 2007; https://doi.org/10.1038/
ni1483 PMID: 17603488
26. Kumar P, Vahedi-Faridi A, Saenger W, Merino E, Lo´pez de Castro JA, Uchanska-Ziegler B, et al. Struc-
tural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens. J Biol Chem. 2009;
https://doi.org/10.1074/jbc.M109.038497 PMID: 19617632
27. Case D.A., Cerutti D.S., Cheatham T.E. III, Darden T.A., Duke R.E., Giese T.J., Gohlke H., Goetz A.W.,
Greene D., Homeyer N., Izadi S., Kovalenko A., Lee T.S., LeGrand S., Li P., Lin C., Liu J., Luchko T.,
Luo R., Mermelstein D., Merz K.M., Monard G., DMY H. and PAK. Amber 2017. University of California,
San Francisco. 2017. doi:citeulike-article-id:2734527
28. Olsson MHM, SØndergaard CR, Rostkowski M, Jensen JH. PROPKA3: Consistent treatment of inter-
nal and surface residues in empirical p Kapredictions. J Chem Theory Comput. 2011; https://doi.org/10.
1021/ct100578z PMID: 26596171
29. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential
functions for simulating liquid water. J Chem Phys. 1983; https://doi.org/10.1063/1.445869
30. Darden T, York D, Pedersen L. Particle mesh Ewald: An Nlog(N) method for Ewald sums in large sys-
tems. J Chem Phys. 1993; https://doi.org/10.1063/1.464397
31. DeLano WL. The PyMOL Molecular Graphics System, Version 1.8. Schro¨dinger LLC. 2014; https://doi.
org/10.1038/hr.2014.17
32. Craig DB, Dombkowski AA. Disulfide by Design 2.0: A web-based tool for disulfide engineering in pro-
teins. BMC Bioinformatics. 2013; https://doi.org/10.1186/1471-2105-14-346 PMID: 24289175
33. Ljunggren HG, Stam NJ, O¨ hle´n C, Neefjes JJ, Ho¨glund P, Heemels MT, et al. Empty MHC class I mole-
cules come out in the cold. Nature. 1990; https://doi.org/10.1038/346476a0 PMID: 2198471
34. Williams AP, Peh CA, Purcell AW, McCluskey J, Elliott T. Optimization of the MHC class I peptide cargo
is dependent on tapasin. Immunity. 2002; 16: 509–520. https://doi.org/10.1016/S1074-7613(02)00304-
7 PMID: 11970875
35. Madden DR, Gorga JC, Strominger JL, Wiley DC. The three-dimensional structure of HLA-B27 at 2.1 Å
resolution suggests a general mechanism for tight peptide binding to MHC. Cell. 1992; https://doi.org/
10.1016/0092-8674(92)90252-8
36. Rein RS, Seemann GH, Neefjes JJ, Hochstenbach FM, Stam NJ, Ploegh HL. Association with beta 2-
microglobulin controls the expression of transfected human class I genes. J Immunol. 1987;
37. Bird LA, Peh CA, Kollnbeger S, Elliott T, McMichael AJ, Bowness P. Lymphoblastoid cells express
HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Euro-
pean Journal of Immunology. 2003. https://doi.org/10.1002/eji.200323678 PMID: 12616495
38. Abualrous ET, Saini SK, Ramnarayan VR, Ilca FT, Zacharias M, Springer S. The carboxy terminus of
the ligand peptide determines the stability of the MHC class i molecule H-2Kb: A combined molecular
Stabilized HLA-B27 reaches the cell surface without peptide
PLOS ONE | https://doi.org/10.1371/journal.pone.0200811 August 2, 2018 18 / 20
dynamics and experimental study. PLoS One. 2015; https://doi.org/10.1371/journal.pone.0135421
PMID: 26270965
39. Fisette O, Wingbermu¨hle S, Scha¨fer L V. Partial dissociation of truncated peptides influences the struc-
tural dynamics of the MHCI binding groove. Front Immunol. 2017; https://doi.org/10.3389/fimmu.2017.
00408 PMID: 28458665
40. Mage MG, Dolan MA, Wang R, Boyd LF, Revilleza MJ, Robinson H, et al. The Peptide-Receptive Tran-
sition State of MHC Class I Molecules: Insight from Structure and Molecular Dynamics. J Immunol.
2012; 189: 1391–1399. https://doi.org/10.4049/jimmunol.1200831 PMID: 22753930
41. Chen L, Shi H, Yuan J, Bowness P. Position 97 of HLA-B, a residue implicated in pathogenesis of anky-
losing spondylitis, plays a key role in cell surface free heavy chain expression. Ann Rheum Dis. 2017;
76: 593–601. https://doi.org/10.1136/annrheumdis-2016-209512 PMID: 27515058
42. Blanco-Gelaz MA, Sua´rez-Alvarez B, Gonza´lez S, Lo´pez-Va´zquez A, Martı´nez-Borra J, Lo´pez-Larrea
C. The amino acid at position 97 is involved in folding and surface expression of HLA-B27. Int Immunol.
2006; https://doi.org/10.1093/intimm/dxh364 PMID: 16361312
43. Antoniou AN, Ford S, Taurog JD, Butcher GW, Powis SJ. Formation of HLA-B27 Homodimers and
Their Relationship to Assembly Kinetics. J Biol Chem. 2004; 279: 8895–8902. https://doi.org/10.1074/
jbc.M311757200 PMID: 14684742
44. Merino E, Galocha B, Va´zquez MN, Lo´pez De Castro JA. Disparate folding and stability of the ankylos-
ing spondylitis-associated HLA-B*1403 and B*2705 proteins. Arthritis Rheum. 2008; 58: 3693–3704.
https://doi.org/10.1002/art.24045 PMID: 19035480
45. Dangoria NS, Delay ML, Kingsbury DJ, Mear JP, Uchanska-Ziegler B, Ziegler A, et al. HLA-B27 misfold-
ing is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic
reticulum. J Biol Chem. 2002; 277: 23459–23468. https://doi.org/10.1074/jbc.M110336200 PMID:
11978783
46. Hughes EA, Hammond C, Cresswell P. Misfolded major histocompatibility complex class I heavy chains
are translocated into the cytoplasm and degraded by the proteasome. Proc Natl Acad Sci U S A. 1997;
94: 1896–901. https://doi.org/10.1073/pnas.94.5.1896 PMID: 9050876
47. Rock KL, Gramm C, Benacerraf B. Low temperature and peptides favor the formation of class I hetero-
dimers on RMA-S cells at the cell surface. Proc Natl Acad Sci U S A. 1991; 88: 4200–4. https://doi.org/
10.1073/pnas.88.10.4200 PMID: 1709736
48. Evans DM, Spencer CCA, Pointon JJ, Su Z, Harvey D, Kochan G, et al. Interaction between ERAP1
and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in
disease susceptibility. Nat Genet. 2011; https://doi.org/10.1038/ng.873 PMID: 21743469
49. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al. Association scan of
14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;
https://doi.org/10.1038/ng.2007.17 PMID: 17952073
50. Keidel S, Chen L, Pointon J, Wordsworth P. ERAP1 and ankylosing spondylitis. Curr Opin Immunol.
Elsevier Ltd; 2013; 25: 97–102. https://doi.org/10.1016/j.coi.2012.11.002 PMID: 23452840
51. Cortes A, Pulit SL, Leo PJ, Pointon JJ, Robinson PC, Weisman MH, et al. Major histocompatibility com-
plex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nat
Commun. 2015; 6. https://doi.org/10.1038/ncomms8146 PMID: 25994336
52. Chen L, Fischer R, Peng Y, Reeves E, McHugh K, Ternette N, et al. Critical role of endoplasmic reticu-
lum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by
HLA-B27. Arthritis Rheumatol. 2014; https://doi.org/10.1002/art.38249 PMID: 24504800
53. Tedeschi V, Vitulano C. The Ankylosing Spondylitis-Associated HLA-B*2705 Presents a B*0702-
Restricted EBV Epitope and Sustains the Clonal Amplification of Cytotoxic T Cells in Patients. Mol Med.
2016; https://doi.org/10.2119/molmed.2016.00031 PMID: 27254288
54. Tran T, Hong S, Edwan J, Colbert RA. ERAP1 Reduces Accumulation of Aberrant and Disulfide-Linked
Forms of HLA-B27 on the Cell Surface. 2017; 10–17. https://doi.org/10.1016/j.molimm.2016.04.002.
ERAP1
55. Haroon N, Tsui FW, Uchanska-Ziegler B, Ziegler A, Inman RD. Endoplasmic reticulum aminopeptidase
1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in
ankylosing spondylitis. Ann Rheum Dis. 2012; 71: 589–595. https://doi.org/10.1136/annrheumdis-
2011-200347 PMID: 22355039
56. Chen L, Ridley A, Hammitzsch A, Al-Mossawi MH, Bunting H, Georgiadis D, et al. Silencing or inhibition
of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and
Th17 responses in ankylosing spondylitis. Ann Rheum Dis. 2016; 75: 916–923. https://doi.org/10.1136/
annrheumdis-2014-206996 PMID: 26130142
Stabilized HLA-B27 reaches the cell surface without peptide
PLOS ONE | https://doi.org/10.1371/journal.pone.0200811 August 2, 2018 19 / 20
57. Cauli A, Shaw J, Giles J, Hatano H, Rysnik O, Payeli S, et al. The arthritis-associated HLA-B*27:05
allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.
Rheumatol (United Kingdom). 2013; https://doi.org/10.1093/rheumatology/ket219 PMID: 23804219
58. Ridley A, Hatano H, Wong-Baeza I, Shaw J, Matthews KK, Al-Mossawi H, et al. Activation-Induced
Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differ-
entiation in Spondyloarthritis. Arthritis Rheumatol. 2016; https://doi.org/10.1002/art.39515 PMID:
26841353
Stabilized HLA-B27 reaches the cell surface without peptide
PLOS ONE | https://doi.org/10.1371/journal.pone.0200811 August 2, 2018 20 / 20
